Unexpected Hair Regrowth in a Patient with Longstanding Alopecia Universalis During Treatment of Recalcitrant Dermatomyositis with the Janus Kinase Inhibitor Ruxolitinib

January 2020 in “ Acta Dermato Venereologica ”

Tanja Fetter, Germán Cuevas-Ríos, Dennis Niebel, Thomas Bieber, Joerg Wenzel

alopecia universalis Janus kinase inhibitor ruxolitinib JAK inhibitors JAK/STAT pathway hair regrowth autoimmune diseases

TLDR Ruxolitinib treatment led to unexpected hair regrowth in a patient with alopecia universalis.

A patient with longstanding alopecia universalis experienced unexpected hair regrowth while being treated for recalcitrant dermatomyositis with the Janus kinase inhibitor ruxolitinib. This case highlighted the potential of JAK inhibitors in promoting hair regrowth in conditions like alopecia universalis, suggesting a possible therapeutic avenue for patients with similar conditions. The findings underscored the importance of further research into the JAK/STAT pathway's role in hair growth and autoimmune diseases.

View this study on medicaljournals.se →

Discuss this study in the Community →

Research cited in this study

2 / 2 results

research JAK Inhibitors and Alopecia Areata

56 citations, January 2019 in “Lancet”

JAK inhibitors help regrow hair in alopecia areata patients, improving their quality of life.

research Alopecia Areata: A Review of Disease Pathogenesis

191 citations, May 2018 in “British journal of dermatology/British journal of dermatology, Supplement”

Alopecia areata is likely an autoimmune disease with unclear triggers, involving various immune cells and molecules, and currently has no cure.

Similar Research

6 / 1000+ results

Alopecia Universalis in an Adolescent Successfully Treated with Upadacitinib: A Case Report and Review of the Literature on the Use of JAK Inhibitors in Pediatric Alopecia Areata

research Alopecia Universalis in an Adolescent Successfully Treated with Upadacitinib: A Case Report and Review of the Literature on the Use of JAK Inhibitors in Pediatric Alopecia Areata

9 citations, January 2023 in “Dermatology and therapy”

A 14-year-old girl with severe hair loss regrew her hair using upadacitinib.

New Drugs Under Investigation for the Treatment of Alopecias

Unexpected Hair Regrowth in a Patient with Longstanding Alopecia Universalis During Treatment of Recalcitrant Dermatomyositis with the Janus Kinase Inhibitor Ruxolitinib

Research cited in this study

research JAK Inhibitors and Alopecia Areata

research Alopecia Areata: A Review of Disease Pathogenesis

Related Community Posts Join

community No hair, don't care! [24/F] :)

community Scalp, eyebrow, eyelash and pubic hair loss.

community Just find a cure already, I am totally done

community The shedding caused by Minoxidil is one of the worst things. 2 months apart each picture

community Actor Jacob Batalon, 26, has a receding hairline. I thought it was pretty cool to see a younger actor being successful, despite dealing with hair loss. His most well known role is Ned Leeds in the Marvel Cinematic Universe, and he is currently the CEO of Sex.

community A meta analysis of 18 popular hair loss treatments. An 2022 guide on efficacy. From finasteride and minoxidil to caffeine shampoo, saw palmetto and biotin. 96 Scientific References included.

Similar Research

research Alopecia Universalis in an Adolescent Successfully Treated with Upadacitinib: A Case Report and Review of the Literature on the Use of JAK Inhibitors in Pediatric Alopecia Areata

research New Drugs Under Investigation for the Treatment of Alopecias

research Efficacy and Safety of Different JAK Inhibitors in the Treatment of Alopecia Areata: A Network Meta-Analysis

research Under Development JAK Inhibitors for Dermatologic Diseases

research Janus Kinase Inhibitors in Dermatology: A Systematic Review

research Immunopathology and Immunotherapy of Inflammatory Skin Diseases